Conclusion
the dossier summarised in one paragraphThe computed 12-month bankruptcy probability of Corden Pharma Brussels is 0.6% (low). The company has been active since 1987 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
Based on State Gazette and CBE data.
Financials
No processed annual-account figures available.
To financials
People & board
No director data processed yet.
To directors Publicationslatest 29-04-2025
29
publications in the State GazetteRegistered office moved from Bruxelles to IxellesAll publications & acts Network & structure
No network or structure data processed.
To structure
Trust signals
3 signalsLong-established
Founded in 1987 — 39 years in business.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).
Administrative Flags
0 events
No administrative flags
Bankruptcy probability (12 mo)
Checked model v1 · free for everyone0.6%
Low
0%0,5%1,5%4%10%≥25%
Higher-failure-rate region
+Long track record
−Lower-risk legal form
−
Statistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?
Company registry (CBE)
Crossroads BankActivities
Vervaardiging van andere organische chemische basisproducten20140Vervaardiging van andere organische chemische basisproducten20140Vervaardiging van farmaceutische grondstoffen21100Vervaardiging van farmaceutische grondstoffen21100Vervaardiging van overige organische chemische basisproducten24140
Primary activity highlighted.
Names & trade names
| Legal name | Corden Pharma Brussels |
Registered office
Louizalaan 523
1050 Elsene, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.